“…In this case, the combined Toxoplasma therapy (pyrimethamine and sulfadiazine) and HAART were benefitial not only to the mother but also prevented transmission to the fetus. Despite this evidence of success in most cases, there have been reports of poor outcomes when an HIVi n f e c t e d m o t h e r h a s C T d u r i n g p r e g n a n c y , w i t h v e r t i c a l t r a n s m i s s i o n o f o n e o r b o t h infections to the fetus and an increase of morbidity and mortality in the mother (Mitchell et al, 1990;O'Riordan & Farkas, 1998;Fernandes et al, 2009). Maternal-fetal transmission of toxoplasmosis due to reactivation of chronic infection during pregnancy occurs in mothers with a very low CD4 cell counts (Minkoff et al, 1997) or in the presence of other immunological disorders (Montoya & Liesenfeld, 2004).…”